The corporate facts, in one place.

A newly formed Nevada C-corporation, headquartered in Salt Lake City, with three operating subsidiaries, a founder-designated three-seat board, and a simple four-class equity structure.

The entity

Legal entity	E4L, Inc. (to be conformed to the name on the Company’s filed Nevada charter)
Form	Nevada C-corporation, newly formed in 2026
Headquarters	Salt Lake City, Utah
Governing law	Nevada (internal-affairs doctrine under the Nevada Revised Statutes)
Origin	A new company formed in 2026; it acquired the assets, IP, subsidiaries, customer base and data of the former XPO Health / NES Health group (a UK-founded business built over the prior two decades), and did not assume the legacy trading liabilities

Subsidiaries

NES Health LLC (US) — owns the FIELD diagnostic platform and the miHealth device IP.
Energy4Life LLC (US) — owns the GEM wearable and consumer platform.
Third operating subsidiary — a third legacy subsidiary being contributed and confirmed in the transfer documentation.

Board of directors

The board has three fixed seats — two filled, one currently open:

Harry Massey — Chairman & CEO; founder and inventor of the acquired bioenergetic platform.
Susan Kichuk — director; PhD business scientist who, as CEO, scaled The Targeted Strategies Group past $11B of in-force policies.
Open seat — to be appointed as the Company scales.

The founder controls the board through his majority ownership and a Founder Common director-designation right that entitles him to designate all three seats of the three-member board (currently Harry Massey, Susan Kichuk and one open seat) — not through any super-voting multiple. See the Team & Organization and Capitalization documents.

Equity structure

A deliberately simple four-class structure with a single 1× non-participating liquidation preference for cash actually invested:

Class A Preferred — new money via SAFE conversion; 1× non-participating, senior (6.85% at the cap — 735,294 shares).
Class B Preferred — legacy cash; 1× non-participating, junior to Class A: Massey Developments $3.2M (pegged to cost) + Kitty Stoneburner ~$1.6M restricted.
Founder Common — Harry Massey; ordinary common economics (one vote per share, no preference); control via majority ownership + board designation.
Common — goodwill holders and employees.

Incentives run through a 14% phantom-equity pool (contractual, cash-settled) — there are no stock options and no ESOP. Full detail is in the Capitalization Summary and the Share Structure & Exit Waterfall.

The offering

SAFEs of up to ~$5.0M with a $73M post-money valuation cap plus a 15% discount, converting into Class A Preferred at the next priced round (at the lower of the cap price or 85% of the round price). Offered under Rule 506(c) of Regulation D to accredited investors only, each verified as accredited before closing — no escrow, no tranching. Investor funds are payable only to the Company’s own bank account, per wiring instructions provided individually after countersignature.

Advisers of record

Craig Weaver — US corporate counsel (formation, share classes, IP contribution, the fundraise).
Azets / Chris Downing — UK tax.
Genesis / Matthew Homan — UK legal.

In progress. The Company’s Nevada charter is filed; a restated-articles Certificate of Amendment establishing the Class A / Class B / Founder Common share-class designations is being completed with counsel and must be effective before any shares issue. The corporate name will be conformed to the name on the Company’s filed Nevada charter. The third subsidiary and the patent-assignment chain are being confirmed in the transfer documentation (see the IP & Chain-of-Title Summary).

Confidential. For accredited investors only. Securities offered under Rule 506(c) of Regulation D; accredited status is verified before any subscription is accepted. This is a summary; the Company’s charter documents, the Disclosure Memorandum and the executed SAFE govern. Company name to be conformed to the name on the Company’s filed Nevada charter.